Synthorx Announces Pricing of Initial Public Offering

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) — Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for…

About Globe Newswire

Nasdaq Globenewswire on NEWSTAGE
View all posts by Globe Newswire →

Leave a Reply

Your email address will not be published. Required fields are marked *